3P Biopharmaceuticals firma un nuevo contrato de colaboración con la compañía holandesa Xenikos

por 3P Biopharmaceuticals

5 years ago
3P Biopharmaceuticals, contrato, colaboración, Xenikos, T-Guard, trasplante

3P Biopharmaceuticals (3P), compañía biotecnológica CDMO especializada en el desarrollo de procesos y fabricación bajo Normas de Correcta Fabricación (GMPs) de medicamentos biológicos y produ...

3P Biopharmaceuticals successfully completes the expansion and improvement of its facilities

por 3P Biopharmaceuticals

5 years ago
facilities, 3P Biopharmaceuticals, bioprocesses, manufacturing plant, Robustness

3P Biopharmaceuticals has successfully completed the project for the expansion and improvement of its facilities in Noáin (Spain) that had been carried out over the past months. The investment exceed...

3P Biopharmaceuticals and Viscofan to collaborate in an innovate advanced therapy project

por 3P Biopharmaceuticals

6 years ago
Cardiomesh, cell therapy product, GMP manufacturing

Cardiomesh is the project in which 3P Biopharmaceuticals and Viscofan are collaborating to develop and manufacture an innovative cell therapy product. 3P Biopharmaceuticals has executed the tuning, th...

3P Biopharmaceuticals incorporates a LIMS, a Laboratory Information Management Systems

por 3P Biopharmaceuticals

6 years ago
LIMS, 3P Biopharmaceuticals

This acquisition has involved an investment of approximately 200.000 € (system, implementation and associated services) and it is part of an investment plan that 3P is conducting during 2018 with th...

3P Biopharmaceuticals is proud to announce a new collaboration agreement signed with the Swedish company Intervacc

por 3P Biopharmaceuticals

7 years ago
Intervacc, 3P Biopharmaceuticals, vaccine

Intervacc has signed a Letter of Intent and an agreement on first mile stones with 3P Biopharmaceuticals in Pamplona, Spain, for contract manufacturing of Strangvac®, Intervacc´s recombinant vaccine...

3P Biopharmaceuticals reunió a más de 150 invitados en su décimo aniversario

por 3P Biopharmaceuticals

7 years ago
3P Biopharmaceuticals

3P Biopharmaceuticals es una compañía biotecnológica CDMO (Contract Development Manufacturing Organization) especializada en el desarrollo de procesos y fabricación GMP de medicamentos biológicos...

Las claves para seleccionar el mejor partner para el desarrollo y producción de biológicos de la mano de 3PBiopharmaceuticals en CPhI

por 3P Biopharmaceuticals

9 years ago
Mesa redonda, CPhI, Covance, Charles River, Menarini Biotech, ASEBIO, 3P Biopharmaceuticals

“El reto de selección de partner CRO y CMO: cómo elegir al mejor compañero de viaje en la aventura del desarrollo y fabricación de biológicos” acogerá las ideas y experiencias de ejecutivos ...

3P Biopharmaceuticals Advanced Therapy area develops a GMP buffer involved in a novel treatment for the Age-Related Macular Degeneration (AMD)

por 3P Biopharmaceuticals

9 years ago
TargetAMD, neovascularisation, Age-related Macular Degeneration

The project has received funding from the European Union’s Seventh Framework Programme and aims to develop a non-viral gene therapeutic approach for the treatment of this neurodegenerative disease o...

Infarco, the parent company of Cinfa, makes the leap to biotechnology

por 3P Biopharmaceuticals

10 years ago
Infarco, 3P Biopharmaceuticals

The total investment of Infarco in the companies of the group, which currently employ 1,100 people, will be more than 200 million Euros over the next five years.

3P Biopharmaceuticals keeps focused in international markets

por 3P Biopharmaceuticals

10 years ago
3P Biopharmaceuticals

With more than 60% of its portfoloio composed of international clients, 3P has active presence in major international markets such as USA, Australia, Mexico, Argentina, France, Norway, Italy, UK, Belg...

The cell therapy area at 3P Biopharmaceuticals receives GMP certification of an allogeneic cell therapy medicine

por 3P Biopharmaceuticals

10 years ago
células madre, servicios CRO CMO

This past April, 3P Biopharmaceuticals obtained GMP (Good Manufacturing Practices) certification for a manufacturing process of a cellular medication destined for allogeneic therapy treatments.

Entrevista con Dámaso Molero, director general de 3P:

por 3P Biopharmaceuticals

11 years ago
proteínas

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el desarrollo de fármacos biosimilares" Trescientas compañías han participado en el primer foro Biolatam, del sector bio...